Binding of mannose-binding lectin (MBL), a C-type lectin, and its associated serine proteases, MASP-1 and MASP-2, to cell surface carbohydrates activates the lectin complement pathway. As MBL plays an important role in innate immunity, it has been cloned and characterized in several species. While the pig may be used as a source of organs/tissues for xenotransplantation, little is known about its MBL, thus, we report the isolation of three monomeric forms of MBL from porcine serum. Sodium dodecyl sulphate±polyacrylamide gel electrophoresis and Coomassie staining of reduced porcine MBL revealed the presence of three monomeric forms with approximate molecular masses of 30 000, 32 000 and 34 000. Protein sequencing identi®ed these monomeric forms as one single protein, suggesting post-translational modi®cation. Western blot analysis demonstrated the cross-reactivity of anti-human MBL polyclonal antibody with porcine MBL. A full-length porcine liver MBL cDNA was isolated and the predicted amino acid sequence exhibited 64 . 9% identity with human MBL and 50 . 2% and 56 . 7% identity with rat A and C MBL, respectively. Furthermore, Northern blot analysis demonstrated the presence of a single (y1 . 4±1 . 6 kilobase pair) transcript in porcine liver. Addition of puri®ed porcine MBL to MBL-de®cient human sera augmented N-acetylglucosamine inhibitable C3 deposition to mannan-coated plates in a dosedependent manner. Taken together, these data demonstrate that porcine and human MBL are highly conserved, sharing structural and functional characteristics.
INTRODUCTION
The human complement system is a host defence mechanism and can be activated by three separate pathways: the classical, the alternative and the lectin pathways. The classical pathway is activated following antibody±antigen interactions leading to deposition of C1q and the activation of C1s and C1r. The alternative pathway can be triggered by a number of mechanisms, such as haemodialysis, cardiopulmonary bypass, tissue plasminogen activator and yeast cell walls (zymosan). The lectin pathway is activated upon binding of mannosebinding lectin (MBL) and its two-associated serine proteases (i.e. MASP-1 and MASP-2) to a carbohydrate ligand which then cleave C2 and C4 to form the classical C3 convertase. 1, 2 The three pathways merge at C3 and cleavage of C3 culminates in the activation of the terminal complement pathway and ultimately in formation of the terminal complement complex (C5b-9). 3 MBL is a C-type lectin and can speci®cally bind to terminalreducing sugars such as N-acetylglucosamine (GlcNAc), mannose, fructose and glucose present on micro-organisms. Human MBL circulates in the blood as large (200 000± 650 000 MW) homo-oligomers consisting of 9±18 monomers of about 32 000 MW each. Each monomer consists of an amino-terminal region rich in cysteine residues, a collagenlike domain composed of 18±20 tandem repeats of a Gly-X-Y sequence, a neck region and a carboxy-terminal carbohydrate recognition domain region. 4±6 Human MBL is present in a single form. However, it has been reported that rats and mice present two structurally and functionally distinct MBL proteins, MBL-A and MBL-C. 6, 7 MBL is believed to be an important constituent of innate immunity, with de®ciencies in MBL being associated with recurrent infections in infants. 8 While MBL is known to have a wide array of binding activity to carbohydrate moieties on micro-organisms, lectins are quite selective in respect to host glycoproteins. The pig may, in the near future, be a source of xenotransplantable tissues/ organ, yet little is known about porcine MBL. Thus, to further the characterization of this interesting animal lectin, we have characterized porcine MBL protein and cDNA (GenBank accession number: AF164576). Porcine and human MBL display striking homology at the structural and functional levels.
MATERIALS AND METHODS

Puri®cation of MBL
MBL was puri®ed from human and porcine sera with modi®cations to the previously published method. 9 Brie¯y, sera (1 l) were precipitated with 10% polyethylene glycol 3500 (w/v) and centrifuged at 10 000 g for 10 min. The pellet was suspended in 750 ml of ice-cold TBS-TCa 2+ (50 mmol/l Tris; 150 mmol/l NaCl; 0 . 05% Tween-20; 20 mmol/l CaCl 2 , pH 7 . 8). Following centrifugation at 10 000 g for 5 min, the supernatant was loaded onto a mannan±Sepharose column (Sigma, St Louis, MO) equilibrated with TBS-TCa 2+ . Following extensive washing, the proteins were eluted with phosphate-buffered saline (PBS) -TEDTA (50 mmol/l Tris; 150 mmol/l NaCl; 0 . 05% Tween-20; 10 mmol/l ethylenediaminetetraacetic acid, pH 7 . 8). The eluate was calci®ed (40 mmol/l) and loaded onto a maltose column (5 ml column volume); washed extensively with TBS-TCa 2+ and the bound proteins were eluted with GlcNAc (100 mmol/l) in TBS-TCa 2+ . Immunoglobulin G (IgG) or IgM contamination was observed by Western blot analysis in the porcine, but not human MBL preparations. Porcine IgG and IgM contamination was removed by af®nity chromatography using rabbit polyclonal anti-porcine IgG and IgM columns.
MBL-de®cient human sera
Human serum de®cient in MBL was made as previously described. 10 Brie¯y, human serum was treated with phenylmethylsulphonyl¯uoride (2 mmol/l) and loaded onto a mannan±Sepharose column. The eluate, MBL-de®cient human serum, was collected and dialysed against Hanks' buffered salt solution containing calcium and magnesium, overnight at 4u. MBL-de®cient human serum induced lysis of sensitized chicken red blood cells, thus demonstrating an intact classical complement pathway. 10 Western blot analysis Polyclonal antibodies against human MBL were raised by immunizing rabbits with subcutaneous puri®ed human MBL (50 mg MBL in Titermax, Sigma). After several rounds of immunization, serum from a rabbit (R2.2) were collected 10 days after a ®nal immunization and rabbit IgG antibodies were puri®ed by protein G chromatography.
Porcine and human MBL were fractionated on a 9% polyacrylamide gel under non-reducing conditions. A broadrange protein standard (Bio-Rad, Hercules, CA) was used to establish the relative molecular weights of porcine and human MBL. The proteins were transferred onto nitrocellulose and the membrane was blocked with 10% non-fat dry milk (NFDM) in PBS-TB (PBS containing 0 . 1% Tween-20 and 0 . 1% bovine serum albumin) overnight. The membrane was then incubated with horseradish peroxidase-conjugated anti-human MBL polyclonal antibody (1 : 5000 dilution) in 3% NFDM in PBS-TB for 1 hr at 4u. The membrane was washed with PBS-TB and developed with the SuperSignal system (Pierce, Rockford, IL) and X-ray ®lms (Kodak).
Peptide sequencing and mass spectroscopy Porcine MBL (10 mg) was resolved on a 9% polyacrylamide gel under reducing conditions. Three Coomassie-stained protein bands with approximate molecular masses of 30 000, 32 000 and 34 000 were excised and subjected to internal peptide sequencing (Harvard Microchemistry Facility, Boston, MA), by microcapillary reverse-phase high-performance liquid chromatography (HPLC) nano-electrospray tandem mass spectroscopy (mlC/MS/MS) on a Finnigan LCQ quadrupole ion trap mass spectrometer (Finnigan, Piscataway, NJ).
Porcine MBL cDNA isolation Reverse transcription±polymerase chain reaction (RT-PCR) ampli®cation was utilized to determine the presence of a MBL transcript in porcine liver tissue. Brie¯y, total RNA was puri®ed from freshly isolated porcine liver tissue (Strategene, La Jolla, CA). Puri®ed RNA was used as template for oligo-dT primed reverse transcription using the Access RT-PCR System (Promega, Madison, WI). Oligonucleotides for RT-PCR reactions were designed based on the conserved regions of human and bovine MBL cDNA sequences (GenBank accession numbers NM000587and D73408). The forward (5k-tttgtggatctgacaggaaagggggtg-3k) and reverse (5k-ggagaaaagggagaaccaggtcaagga-3k) primers were synthesized. The reverse transcribed cocktail (2 ml) was used as a template for PCR ampli®cation using 10 pmol of each primer, 1 unit of DNA Taq polymerase, 10 mmol/l of each dNTP and 5 ml of 10r PCR buffer containing MgCl 2 (total volume of 50 ml) added to the reaction mixture. PCR ampli®cation was performed using the following conditions: a single cycle of 94u for 90 seconds followed by 30 cycles of 94u for 1 min, 55u for 2 min and 72u for 2 min and a ®nal extension cycle of 72u for 10 min. PCR bands of the predicted size (based on human MBL sequence) were excised from low-melting-point agarose and ligated into the PGEM-T vector (Promega). Several colonies were selected and the puri®ed plasmids were sequenced using an Automated Fluorescence DNA Sequencer (Children's Hospital Core Facility, Boston, MA). This strategy resulted in isolation of an internal 370-base pair (bp) fragment, thus necessitating application of 5k and 3k rapid ampli®cation of cDNA ends (RACE). The Marathon Ampli®cation Kit (Clontech, Palo Alto, CA) was used to obtain the 5k and 3k ends of the porcine liver MBL cDNA. Poly(A) + liver RNA (1 mg) was used as the starting material for cDNA synthesis and the RACE was carried out as described by the manufacturer using 5k-ggagaaaagggagaaccaggtcaaggact-3k and 5k-tcaccccctttcctgtcagatccacaaa-3k as 5k and 3k porcine liver MBL cDNA-speci®c primers, respectively.
Northern blot analysis RNA was extracted from frozen tissue and Northern blot analysis was performed according to standard procedures. Total RNA (10 mg) was resolved on a 0 . 9% agarosex2 . 2 mol/l formaldehyde gel. After hydrolysis (50 mM NaOH/10 mmol/l NaCl and neutralization in 10 mmol/l Tris±HCl, pH 7 . 5) RNA was transferred to a nylon membrane overnight by capillary transfer in 2rSSC (0 . 3 mol/l NaCl, 30 mmol/l sodium citrate, pH 7 . 0). Prehybridization was carried out in 50% formamide, 6rSSC, 5rDenhardt's solution, 1% sodium dodecyl sulphate (SDS) and 150 mg/ml of non-denatured and 150 mg/ml of denatured ®sh sperm DNA (Boehringer Mannheim, Germany) for 3±4 hr at 42u. A dimer of the 370-bp fragment of porcine MBL cDNA was radiolabelled using the Prime-a-Gene labelling system (Promega) and puri®ed sequentially through two Sephadex G-50 spin columns. The probe (5 ng/ml at 2r10 9 counts per min/mg) was denatured by boiling and was hybridized overnight at 42u. The blot was washed twice in 2rSSC/0 . 1% SDS for 10 min at room temperature, followed by two washes in 0 . 2 SSC/0 . 1% SDS for 10 min at room temperature. The blot was exposed to Kodak MS autoradiography ®lm and developed.
MBL-dependent C3 deposition enzyme-linked immunosorbent assay (ELISA) Radioimmunoassay 96-well plates were coated with 100 ml of 0 . 5 mg/ml mannan in sodium carbonate/bicarbonate buffer pH 9 . 6 and incubated overnight at 4u as described. Plates were then washed three times with PBS buffer containing 0 . 5% Tween-20 and washed once with PBS buffer followed by a second wash with veronal-buffered saline (VBS: 141 mmol/l NaCl and 1 . 8 mmol/l sodium barbital). Five per cent MBLde®cient human serum containing puri®ed porcine MBL (0±250 ng/ml; 100 ml) or human MBL (0±60 ng/ml; 100 ml) was added to each well and incubated for 0 . 5, 1, or 2 hr at 37u. Plates were then washed four times with PBS buffer containing 0 . 5% Tween-20. Human C3 deposition was detected by addition of 50 ml of 1 : 3000 dilution of horseradish peroxidase-conjugated goat anti-human C3 (ICN, Costa Mesa, CA) to each well and incubated at 20u for 1 hr. The plates were washed four times and 50 ml of 2,2k-azino-bis(3-ethylbenzthiazoline-6-sulphonic) acid (ABTS) was added to each well and the plates were read at 405 nm using a microplate reader (Molecular Devices, Sunnyvale CA). GlcNAc (50 mmol/l), an inhibitor of the lectin complement pathway, was added to some wells to inhibit lectin pathway activation. Non-speci®c background absorbance consisted of wells containing VBS buffer without sera. All ELISA experiments were performed in triplicate.
RESULTS
Puri®cation of porcine MBL
Puri®ed porcine (2 mg) and human (2 mg) MBL were fractionated on a 9% SDS±polyacrylamide gel electrophoresis (PAGE) under partially reduced conditions (Fig. 1) . Coomassie staining of human MBL demonstrated monomeric (32 000), dimeric (64 000), trimeric (96 000) and higher molecular mass forms of human MBL. Porcine MBL demonstrated three monomeric forms with approximate molecular masses of 30 000, 32 000, and 34 000.
Puri®ed porcine (1 mg) and human (500 ng) MBL were fractionated on a 9% SDS±PAGE under non-reduced conditions (Fig. 2) . Rabbit anti-human polyclonal antibody (R2.2) recognized non-reduced human and porcine MBL by Western blot analysis. Cross-reactivity of the anti-human polyclonal antibody con®rmed the presence of similar epitopes between porcine and human MBL.
Cloning of porcine MBL cDNA
In order to clone porcine MBL, an initial RT-PCR reaction was carried out on porcine liver mRNA using oligonucleotides based on the conserved cDNA regions of human and bovine MBL cDNA sequence. A 370-bp PCR band was obtained which, following nucleotide sequencing was positively identi®ed as a MBL homologue. This PCR product corresponded to position 300±670 bp of human MBL cDNA. A full-length porcine liver MBL cDNA of 723 bp and an open reading frame of 241 amino acids was obtained (data not shown; GenBank accession number AF164576) using RACE. The deduced amino acid sequences of porcine and human MBL were aligned and demonstrated a high degree of identity (Fig. 3) . Microcapillary reverse-phase HPLC nano-electrospray tandem mass spectroscopy (mlC/MS/MS) analysis con®rmed that the three isoforms of pMBL present on the Coomassie-stained gel Human (H; 500 ng) and porcine MBL (P; 1 mg) were resolved on a 9% gel via SDS±PAGE under non-reducing conditions, transferred onto a nitrocellulose membrane and reacted with horseradish peroxidaseconjugated rabbit anti-human MBL polyclonal antibody (R2.2).
were the same protein, suggesting post-translational modi®ca-tion (see underlined residues in Fig. 3) . Interestingly, the 30 000 band also contained a human MASP-2 homologue.
Northern blot analysis
To investigate the presence of porcine MBL transcript(s), liver poly(A) + RNA was subjected to Northern blot analysis. Upon hybridization of liver mRNA with a 370-bp radiolabelled porcine MBL cDNA probe, a single transcript with an approximate molecular weight of 1 . 4±1 . 6 kbp was detected (Fig. 4) .
MBL-dependent C3 deposition ELISA
C3 deposition onto mannan-coated plates was measured by ELISA to evaluate whether porcine MBL could functionally restore lectin complement pathway activation in human MBLde®cient human sera. Addition of puri®ed human MBL (top panel, Fig. 5 ) to MBL-de®cient human sera restored C3 deposition in a dose-dependent manner. Maximum C3 deposition was obtained with approximately 50 ng/ml of human MBL and this is equivalent to the amount of human MBL present in human sera (1±2 mg/ml). 2,11 Addition of puri®ed porcine MBL (bottom panel, Fig. 5 ) was less effective than human MBL in restoring C3 deposition, but the effect was dose-dependent with maximum C3 deposition observed at approximately 200 ng/ml porcine MBL. Addition of GlcNAc (50 mmol/l) inhibited C3 deposition, demonstrating that porcine or human MBL can be inhibited by GlcNAc in this assay. Thus, these data indicate that puri®ed porcine MBL functionally restores the lectin complement pathway in MBLde®cient human sera.
Since porcine MBL-induced C3 deposition was less, we speculated that pharmacokinetics may in¯uence human C3 cleavage. As shown in Fig. 6 , increasing the incubation period from 0 . 5 to 2 hr increased GlcNAc inhibitable C3 deposition. Equivalent C3 deposition was observed when MBL-de®cient human serum was supplemented with human MBL (60 ng/ml) and incubated for 30 min compared with porcine MBL (250 ng/ml) supplementation and incubation for 1 or 2 hr. These data demonstrate that longer periods of incubation are required for ef®cient C3 deposition by porcine MBL-mediated human lectin pathway activation compared to the intact human system.
DISCUSSION
MBL homologues have been identi®ed in several species including monkey, cow, rabbit, rat and mouse.
7,12±14 The primary sequence of human MBL has been elucidated and the four domains have been characterized based on their homology with other lectins. 5 Unlike human MBL, two structurally and functionally distinct MBL isoforms, MBL-A and MBL-C, are known to be present in rats and mice. 15 The ability of rat MBL-A to activate complement may be related to the cysteine content of the amino-terminal region of the MBL protein backbone. 15 The amino terminus of MBL-C in rat and mouse has two cysteines, whereas MBL-A, human MBL and, as we now describe, porcine MBL have three cysteines. The presence of these cysteines allows the formation of functionally active multimeric MBL forms. 15 Porcine liver MBL cDNA unveiled the striking overall structural homology of porcine MBL to human MBL. Porcine MBL shares an overall identity to rat MBL-A and -C proteins of 50 . 2% and 56 . 7%, respectively. Human (248 amino acids; Accession #4557739) and porcine MBL (241 amino acids) share an overall identity of 64 . 9% at the amino acid level (allowing for eight gaps). Thus, at the amino acid level, porcine MBL is more similar to human than to rat MBL. Puri®ed porcine MBL functionally replaced human MBL and increased C3 deposition of MBL-de®cient human sera in the mannan assay. C3 deposition was inhibited by GlcNAc, demonstrating that complement activation was MBL-dependent. Furthermore, these data demonstrate that GlcNAc can functionally inhibit porcine MBL.
SDS±PAGE demonstrated the presence of three monomeric forms of porcine plasma MBL under reducing conditions. The presence of three monomeric forms of porcine MBL supports the previously published observation by Storgaard and colleagues. 16 However, microcapillary reverse-phase HPLC nano-electrospray tandem mass spectroscopy (mlC/ MS/MS) analysis con®rmed that the three isoforms of porcine MBL were the same protein, suggesting post-translational modi®cation. These data are different from those presented by Storgaard and colleagues. 16 Furthermore, we established the presence of a single (y1 . 4±1 . 6 kbp) liver transcript. While we cannot categorically rule out the possible presence of another porcine cDNA for MBL, our data suggest that the three porcine monomeric isoforms isolated by our procedures are the same protein with post-translational modi®cations. We observed functional inhibition of porcine MBL-mediated lectin complement pathway activation in MBL-de®cient human sera using GlcNAc, whereas a previous study demonstrated that porcine MBL did not bind to GlcNAc-agarose. 16 The inability of porcine MBL to bind GlcNAc-agarose may be a result of inef®cient coupling of GlcNAc to agarose. Furthermore, we used GlcNAc to elute the proteins from a maltose column that were then identi®ed by microcapillary reverse-phase HPLC nano-electrospray tandem mass spectroscopy (mlC/MS/MS) to be porcine MBL isoforms. Thus, the porcine MBL that was isolated by our methods reveals a single protein with posttranslational modi®cations.
Activated complement is known to induce tissue-mediated injury by several mechanisms. Although a collection of studies has demonstrated the involvement of complement in a number of disease states, the speci®c role of MBL still remains unknown. Identi®cation of the important residues in the carbohydrate recognition domain of the protein could potentially unveil the structural interactions and the binding selectivity of MBL. The observation that porcine MBL can functionally activate the lectin pathway in MBL-de®cient human sera may have importance in xenotransplantation or other diseases involving MBL.
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